Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
  • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
  • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Definitions

• the invention relates to a new isomerization process for the methyl radical at 10 of erythromycin derivatives
• a subject of the invention is an isomerization process characterized in that a compound of formula (I A ): ##STR3## in which either X and Y form together a 3-oxo radical, or X represents a hydrogen atom and Y represents either a radical: ##STR4## in which R 2 represents a hydroxyl radical or an O-acyl radical containing from 2 to 20 carbon atoms, or an O-alkyl radical, containing from 2 to 20 carbon atoms, or an NH 2 radical,
• R 1 represents a hydrogen atom or a methyl radical
• Z represents a hydrogen or an acyl radical containing from 2 to 20 carbon atoms
• R represents a hydrogen atom, an NH 2 radical or a (CH 2 ) n Ar, NH(CH 2 ) n Ar or N ⁇ CH(CH 2 ) n Ar radical in which n represents an integer comprised between 1 and 6, and Ar represents an optionally substituted aryl or heteroaryl radical, in the form of the 10 ⁇ isomer or a mixture of 10 ⁇ and 10 ⁇ isomers, is subjected to the action of a basic agent in order to obtain the corresponding compound of formula (I) in which the methyl radical at 10 is in the ⁇ position: ##STR5## and in which R, R 1 , X and Y retain their previous meaning and Z' represents a hydrogen atom or an acyl radical containing from 2 to 20 carbon atoms.
• the acyl radical is preferably an acetyl, propionyl, butyryl, isobutyryl, n-valeryl, isovaleryl, tervaleryl and pivalyl radical, or a benzyl radical.
• aryl radical is preferably meant a phenyl or naphthyl radical
• heteroaryl radical is meant a radical containing one or more heteroatoms preferably chosen from oxygen, sulphur or nitrogen, it can be one of the following radicals: thienyl, furyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, thiadiazolyl, pyrazolyl, or isoxazolyl, a pyridyl, pyridazinyl, or pyrazinyl radical, an indolyl, benzofuryl, benzothienyl, quinolinyl or pyridyl-imidazolyl radical.
• a more particular subject of the invention is a process characterized in that the operation is carried out in the presence of a basic agent, preferably in a catalytic quantity, Z and Z' representing a hydrogen atom.
• the basic agent is preferably potash or also a tetraalkylammonium hydroxide for example tetrabutylammonium hydroxide or bromide or DBU (1,8-diazabicyclo [5-4-0]undec-7-ene) or an alkaline carbonate for example sodium or potassium carbonate or soda or tripotassium phosphate or also sodium methylate.
• phase transfer agent for example tetrabutyl ammonium bromide.
• a quite particular subject of the invention is a process characterized in that the operation is carried out in a solvent which can be for example tetrahydrofuran, 1-methyl 2-pyrrolidonone in aqueous solution, methylene chloride and more particularly an alcohol in particular methanol and in this way the corresponding compound in which Z' represents a hydrogen atom, or an acyl radical containing from 2 to 20 carbon atoms is obtained.
• a solvent which can be for example tetrahydrofuran, 1-methyl 2-pyrrolidonone in aqueous solution, methylene chloride and more particularly an alcohol in particular methanol and in this way the corresponding compound in which Z' represents a hydrogen atom, or an acyl radical containing from 2 to 20 carbon atoms is obtained.
• a more particular subject of the invention is:
• the invention relates to a process which allows the conversion of compounds of formula (I A ) in which the methyl radical at 10 is in the ⁇ position or a mixture of 10 ⁇ and 10 ⁇ into the compounds of formula (I) in which the methyl radical at 10 is in the 10 ⁇ position.
• a mixture of 10 ⁇ and 10 ⁇ isomers is obtained, therefore if the process described in the Patent EP 676409 is followed, the following reaction is obtained: ##STR7## the product (I A ) obtained is a mixture of ⁇ isomer and ⁇ isomer, as indicated in Example 1 of the Patent EP 676409.
• the 10 ⁇ product is a product endowed with useful antibiotic properties, it also allows the preparation of other antibiotic products described and claimed in the Patent Application 676409 according to the process: ##STR8##
• the compounds endowed with useful antibiotic properties are those in which the methyl radical at 10 is in the ⁇ position. It is therefore useful from an industrial point of view to isomerize the 10 ⁇ product or 10 ⁇ and 10 ⁇ mixtures into the 10 ⁇ product.
• the process according to the invention in particular allows the isomerization into the 10 ⁇ isomer of the products of formula (I A ) in which R is an NH 2 radical, those in which R is a hydrogen atom, or also those in which R is a (CH 2 ) n Ar, NH--(CH 2 ) n Ar or N ⁇ CH(CH 2 ) n Ar radical in which n and Ar retain their previous meaning.
• the isomerization yield is of the order of 90%.
• the reaction medium is maintained under agitation for 20 hours at 20 ⁇ 22° C.
• demineralized water is introduced while controlling the temperature at 20/22° C. using an ice+water bath, the pH is adjusted to 10 with acetic acid qs ( ⁇ 0.250 ml), agitation is carried out for 3 hours at 20/22° C., followed by cooling down to 0+2° C., agitation is carried out for 1 hour at 0°+2° C., followed by separation by clarification using:

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Biochemistry (AREA)
• Genetics & Genomics (AREA)
• Biotechnology (AREA)
• Engineering & Computer Science (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Saccharide Compounds (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=9492104

Family Applications (1)

Country Status (28)

Cited By (12)

Families Citing this family (1)

Citations (1)

• 1996
  • 1996-05-14 FR FR9605966A patent/FR2748746B1/fr not_active Expired - Lifetime
• 1997
  • 1997-05-13 HU HU9901158A patent/HU226676B1/hu unknown
  • 1997-05-13 CZ CZ19983557A patent/CZ289644B6/cs not_active IP Right Cessation
  • 1997-05-13 ES ES97924078T patent/ES2171943T3/es not_active Expired - Lifetime
  • 1997-05-13 UA UA98126445A patent/UA55412C2/uk unknown
  • 1997-05-13 US US09/180,641 patent/US6022965A/en not_active Expired - Lifetime
  • 1997-05-13 DK DK97924078T patent/DK0912591T3/da active
  • 1997-05-13 JP JP54059497A patent/JP3304098B2/ja not_active Expired - Lifetime
  • 1997-05-13 CA CA002254795A patent/CA2254795C/fr not_active Expired - Lifetime
  • 1997-05-13 EA EA199801008A patent/EA000939B1/ru not_active IP Right Cessation
  • 1997-05-13 EP EP97924078A patent/EP0912591B1/fr not_active Expired - Lifetime
  • 1997-05-13 GE GEAP19974602A patent/GEP20012418B/en unknown
  • 1997-05-13 DE DE69710468T patent/DE69710468T2/de not_active Expired - Lifetime
  • 1997-05-13 AT AT97924078T patent/ATE213251T1/de active
  • 1997-05-13 AU AU29663/97A patent/AU720721B2/en not_active Expired
  • 1997-05-13 PL PL97329809A patent/PL183467B1/pl unknown
  • 1997-05-13 CN CNB971963835A patent/CN1160366C/zh not_active Expired - Lifetime
  • 1997-05-13 BR BR9709243A patent/BR9709243A/pt not_active Application Discontinuation
  • 1997-05-13 SK SK1530-98A patent/SK283649B6/sk not_active IP Right Cessation
  • 1997-05-13 KR KR10-1998-0709175A patent/KR100457757B1/ko not_active IP Right Cessation
  • 1997-05-13 NZ NZ332411A patent/NZ332411A/xx not_active IP Right Cessation
  • 1997-05-13 PT PT97924078T patent/PT912591E/pt unknown
  • 1997-05-13 YU YU50398A patent/YU49500B/sh unknown
  • 1997-05-13 WO PCT/FR1997/000840 patent/WO1997043297A1/fr active IP Right Grant
  • 1997-05-13 TR TR1998/02297T patent/TR199802297T2/xx unknown
  • 1997-05-13 IL IL12679697A patent/IL126796A0/xx not_active IP Right Cessation
• 1998
  • 1998-11-10 NO NO19985253A patent/NO310823B1/no not_active IP Right Cessation
  • 1998-11-13 BG BG102925A patent/BG62699B1/bg unknown

Patent Citations (1)

Also Published As

Similar Documents

Legal Events